Latest filing published 23 Feb 2021 for SynAct Pharma AB, €33k.
Filing timeline
BuySaleInsider track record
John Haurum: trading record in brief
This profile gathers the share dealings of John Haurum in SynAct Pharma AB. The record holds 4 filings, for trades running from 20 January 2020 to 18 February 2021.
On the market, this insider has only sold: 1 sale, €33k in total. Since January 2021: no purchases and 1 sale on the market.
The latest filing, published on 23 February 2021, reports an open-market sale of €33k in SynAct Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 6 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to John Haurum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,968 shares@ SEK 55.085447.2% of flowAktieISIN SE0008241491FI:csv-cc2975571077cf23c13f
- 29,840 shares@ SEK 6.7052.2% of flowAktieISIN SE0008241491FI:csv-179f9a4ce96c1420c373
- 29,840 shares0TeckningsoptionISIN SE0013409620FI:csv-0f69e9a13c7275fd249b
- 7,460 shares@ SEK 24.8047.8% of flowBTU (betald tecknad unit)ISIN SE0013409653FI:csv-e24917e03b6f7de59ce6
4 of 4 declarations